glp-1 obesity news The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Dozens of new obesity drugs
Description
Eli Lilly's orforglipron, the first small-molecule GLP-1 pill, transforms diabetes treatment with oral convenience and new patent strategies.
Nourish oral microbiome, digestive, and gut health with Boost Synergy GLP-1 Probiotic featuring Akkermansia muciniphila
Electronic databases including PubMed, Embase, and Web of Science were searched from inception until August 2025 using keywords such as GLP-1 receptor agonist, diabetic retinopathy, glaucoma, age-related macular degeneration, ocular disease, and neuroprotection. The search focused on identifying preclinical studies, large-scale retrospective cohort studies, and post-hoc analyses of major clinical trials that evaluated the utility and potential mechanisms of GLP-1RAs in ophthalmic diseases
Materials and Methods This was a single centre retrospective observational study conducted at a Swiss bariatric reference centre
Learn How Long It Takes for Semaglutide to Suppress Appetite at Sun City, and Discover the Effects in Helping You Manage Hunger and Cravings.
